rheumatologyadvisor3h
FDA Approves Denosumab Biosimilars Ospomyv and Xbryk
The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.
Averto Medical Announces FDA Breakthrough Device Designation for ColoSeal™ Intraluminal Colonic Diversion System
Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted ...
Le Lézard3h
Averto Medical Announces FDA Breakthrough Device Designation for ColoSealtm Intraluminal Colonic Diversion System
Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted ...
The Post-Journal12h
Story Behind The Story
The following article, which first appeared in The Post-Journal in May 2014, is an example of why there can more to a story ...
Observer12h
Act of kindness
The following article, which first saw the light of day in May 2014, is an example of why there can more to a story than ...
Taiwan News16h
Medtronic Malaysia and Malaysian Society of Colorectal Surgeons sign MOU to enhance medical training and education programs
KUALA LUMPUR, Malaysia, Feb. 25, 2025 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, announced that ...
Managed Healthcare Executive3h
Lilly Lowers Prices of Some Zepbound Doses for Self-Pay Patients
Lowering the price of the 2.5 mg dose vial to $349 per month. Lowering the price of the 5 mg dose vial to $499 per month.